Login to Your Account

Heading off investor pain

Though analysts seemed uncertain in February about the commercial future despite favorable phase III data, they came away upbeat from a meeting last week with Trevena Inc. about injectable Olinvo (oliceridine) for moderate to severe acute pain. more »

Our Habitat for All Things Science
Genome therapy promises new blood disease treatments

HONG KONG – In a study led by Australian scientists at University of New South Wales (UNSW), introducing a beneficial natural mutation into blood cells using gene-editing was shown to stimulate production of fetal hemoglobin (Hb), a finding that could lead to a cure for blood diseases.

People with potentially life-threatening blood disorders, such as thalassemia or sickle cell anemia (SCA), have impaired adult Hb, so require life-long treatment with blood transfusions and medications.



Partners in Focus